FOXP3 and neoplasm: Mice vaccinated with MANS‐H adjuvanted vaccines demonstrated significant tumor suppression by promoting the frequency of tumor‐infiltrating CD8+ cells with distinct activated phenotypes and cytotoxic natural killer (NK) cells while suppressing the suppressive innate immune cells and CD4+Foxp3+ Tregs at the tumor site.